DEMOCRATIC REPUBLIC OF THE CONGO / RankWire.AI / – Congo’s Ebola outbreak has expanded more rapidly than any previous epidemic in the country. As of August 3, officials confirmed 3,874 cases and 1,751 deaths. This surge marks it as Congo’s largest recorded Ebola outbreak and the second largest globally. The country hit the 1,000-case mark within 40 days of initiating its response efforts, whereas a major outbreak that started in 2018 took approximately 235 days to reach that level.
Health authorities announced the outbreak on May 15 after laboratories identified Bundibugyo virus in Ituri province. Subsequent investigations revealed that infections had begun months earlier near Mongbwalu. Early symptoms in patients often resembled malaria and other common illnesses. Laboratory testing initially focused on the better-known Zaire Ebola species. This delayed detection allowed the virus additional time to spread within households, clinics, mining areas, and trading communities before testing and isolation measures were scaled up.
The presence of the Bundibugyo strain has also constrained available medical interventions. Approved Ebola vaccines and antibody therapies target Zaire ebolavirus, responsible for Congo’s 2018 to 2020 outbreak. Currently, no licensed vaccine or proven specific treatment exists for Bundibugyo virus disease. Healthcare providers rely on rapid diagnostics, patient isolation, supportive care, infection prevention, and safe burial practices. The World Health Organization has supported enhanced diagnostic capabilities and new treatment trials, but these efforts came after the virus had already spread across multiple regions.
Delayed detection hampered contact tracing efforts
The outbreak has extended beyond Mongbwalu into numerous health zones across eastern and northeastern Congo. While Ituri remains the epicenter, cases have also been reported in North Kivu, South Kivu, Haut-Uele, and Tshopo. By July 30, response teams tracked 17,863 contacts, but follow-up has been inconsistent, especially in regions affected by insecurity and difficult terrain. Additionally, many new patients have appeared outside known contact networks, indicating that surveillance teams have not identified every transmission chain.
Ongoing conflict has further complicated case detection and patient management. Armed attacks have blocked roads, disrupted health activities, and forced some teams to halt field operations. The high mobility of populations—moving between mining sites, markets, towns, and displacement camps—has made daily contact monitoring challenging. Health facilities are also facing shortages of protective gear, trained personnel, transportation, and lab access. Congo had recorded 151 infections and 44 deaths among health workers by July 30, intensifying the strain on the response effort.
Inadequate vaccines and ongoing insecurity fuel rapid transmission
Ebola spreads mainly through direct contact with the blood or body fluids of infected individuals. Risks are heightened in homes, clinics, and burial sites lacking proper infection controls. Over 60% of recent fatalities occurred outside treatment centers, complicating safe burial procedures and contact investigations. To combat this, Congo’s health ministry, the World Health Organization, and Africa CDC have expanded laboratory testing, treatment facilities, border screening, and public outreach initiatives. Despite these efforts, the response has struggled to keep pace with the rapid and widespread emergence of new cases.
Uganda concluded its linked Ebola outbreak on July 28 after 42 days without new local transmissions. Similarly, France reported no secondary cases from its single treated patient. However, Congo remains the epicenter of sustained transmission, with a confirmed death rate near 45% in early August. The faster progression of the outbreak is attributed to late detection and the absence of strain-specific vaccines and treatments. Factors such as missed contacts, conflict, staff shortages, and population movements have expanded the transmission footprint. These conditions set the current Bundibugyo epidemic apart from previous Ebola outbreaks in Congo.